Discover how modern immunotherapy awakens T cells to shrink melanoma tumors, tracked by PET scans and used after surgery to prevent relapse. In this segment, Dr. Morrison provides clinical context ...

Lei Deng, MD, discusses how precision medicine, immunotherapy and rapid molecular testing are improving outcomes for patients ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Key findings from stage 1 of the PRESERVE-003 Phase 3 clinical trial conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) have shown that gotistobart, a novel ...

Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...

• Sarcoma is a complex malignancy, characterized by numerous subtypes each with a unique biology/immune microenvironment; therefore, a histology-specific approach is required for immuno-oncology drug ...

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

In this segment on advanced renal cell carcinoma, Dr. Wulff focuses on the role of cabozantinib across different treatment settings and how clinicians decide between monotherapy and combination ...

Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for ...

In this segment on advanced renal cell carcinoma, Dr. McGregor explores the role of VEGFR TKI monotherapy in patients with favorable risk disease, where NCCN guidelines include both IO-TKI ...

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has reached a significant ...